Back to search

Poland· PL-100505439

Eltrombopag Sandoz

A eltrombopag product containing eltrombopagum, registered in Poland by Sandoz Polska Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC B02BX05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEltrombopag SandozATCB02BX05REGISTER NO.PL-100505439PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Eltrombopag is registered in 15 of 19 countries.

Countries holding a registration under ATC B02BX05 (eltrombopag), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Eltrombopag · ATC B02BX05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of eltrombopag costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Eltrombopag · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$38.37
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Eltrombopagum
Manufacturer
Sandoz Polska Sp. z o.o.
Country
Poland (PL)
ATC code
B02BX05
ATC class
Eltrombopag
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991569945
  • gtin
    05909991569952
  • gtin
    05909991569969

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

175 interactions on record for eltrombopag.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Eltrombopag · interactions on record

175 records

  • 20 severe
  • 153 moderate
  • 2 minor

Most severe, free to view

  • EluxadolineA07DA06severe
  • BerotralstatB06AC06severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Eltrombopag in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eltrombopag products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Elrevolan, Eltrombopag +pharma
  • Belgium · Eltrombopag Krka
  • Bulgaria · Eltrombopag Pharmascience, Eltrombopag Pharmdedict
  • Cyprus · Eltrombopag Msn, Eltrombopag Sandoz
  • Czechia · Eltrombopag Abdi, Eltrombopag Krka
  • Germany · Eltrombopag 1 A Pharma, Eltrombopag Abdi
  • Denmark · Eltrombopag Glenmark, Eltrombopag Krka
  • Estonia · Eltrombopag Krka, Eltrombopag Msn
  • Spain · Eltrombgopa Glenmark, Eltrombopag Aurovitas Spain
  • Finland · Eltrombopag Avansor, Eltrombopag Krka
  • France · Eltrombopag Biogaran, Eltrombopag Eg
  • United Kingdom (Northern Ireland) · Eltrombopag Abdi, Eltrombopag Accord
  • Greece · Eltrombopag Anabiosis, Eltrombopag Faran
  • Croatia · Eltrombopag Alpha-Medical, Eltrombopag Msn
  • Hungary · Elrevolan, Eltrombopag Elpen
  • Ireland · Eltrombopag Clonmel, Eltrombopag Krka
  • Iceland · Eltrombopag Accord, Eltrombopag Coripharma
  • Italy · Elrevolan, Eltrombopag Abdi
  • Liechtenstein · Eltrombopag Accord, Eltrombopag Viatris
  • Lithuania · Eltrombopag Krka, Eltrombopag Msn
  • Latvia · Eltrombopag Krka, Eltrombopag Olpha
  • Malta · Eltrombopag Aspen, Eltrombopag Clonmel
  • Netherlands · Eltrombopag Abdi, Eltrombopag Amarox
  • Norway · Eltrombopag Accord, Eltrombopag Glenmark
  • Portugal · Eltrombopag Bluepharma, Eltrombopag Cipla
  • Romania · Eltrombopag Dr. Reddy’s, Eltrombopag Msn
  • Sweden · Eltrombopag Anabiosis, Eltrombopag Avansor
  • Slovenia · Eltrombopag Krka, Eltrombopag Msn
  • Slovakia · Eltrombopag Glenmark, Eltrombopag Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/07b52ae5-83c6-457e-940e-f209396c448f
GET /v1/drugs/07b52ae5-83c6-457e-940e-f209396c448f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "75 mg",
  "packaging": "05909991569945 ¦ Rpz ¦ 160750\n14 tabl.\n05909991569952 ¦ Rpz ¦ 160751\n28 tabl.\n05909991569969 ¦ Rpz ¦ 160752\n84 tabl.",
  "substance": "Eltrombopagum 75 mg",
  "common_name": "Eltrombopagum",
  "pl_product_id": "100505439",
  "pozwolenie_nr": "28957",
  "auth_procedure": "MRP",
  "authorisation_validity": "2030-03-31"
}

See everything about eltrombopag.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.